Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Vical Incorporated (VICL)

Vical Incorporated (VICL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 15,441
  • Shares Outstanding, K 22,841
  • Annual Sales, $ 1,620 K
  • Annual Income, $ -16,250 K
  • 60-Month Beta 0.31
  • Price/Sales 11.29
  • Price/Cash Flow N/A
  • Price/Book 0.37
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.74
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/06/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.06
  • Number of Estimates 1
  • High Estimate -0.06
  • Low Estimate -0.06
  • Prior Year -0.14
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.60 +12.67%
on 08/30/19
0.93 -27.31%
on 08/28/19
-0.04 (-6.16%)
since 07/30/19
3-Month
0.60 +12.67%
on 08/30/19
1.20 -43.67%
on 05/31/19
-0.47 (-41.22%)
since 05/30/19
52-Week
0.60 +12.67%
on 08/30/19
1.47 -54.01%
on 09/14/18
-0.69 (-50.66%)
since 08/28/18

Most Recent Stories

More News
Brickell Biotech Completes Merger with Vical

Newly Nasdaq-listed BBI focused on developing differentiated therapeutics for treatment of dermatologic disorders

VICL : 0.68 (-15.68%)
BBI : 1.82 (-5.21%)
Vical Stockholders Approve Reverse Stock Split and Merger with Brickell

? Merger Transaction Expected to Close August 31, 2019

VICL : 0.68 (-15.68%)
Options Traders Expect Huge Moves in Vical (VICL) Stock

Investors need to pay close attention to Vical (VICL) stock based on the movements in the options market lately.

VICL : 0.68 (-15.68%)
Moore Kuehn, PLLC Encourages Vical Incorporated (VICL), ASV Holdings, Inc. (ASV), PCM, Inc. (PCMI), WageWorks, Inc. (WAGE), and Acacia Communications, Inc. (ACIA) Investors to Contact Firm

Moore Kuehn, PLLC, a securities law firm located on Wall Street in downtown New York City, is investigating potential claims involving the directors and officers regarding possible breaches of fiduciary...

VICL : 0.68 (-15.68%)
ASV : 7.04 (unch)
PCMI : 35.01 (+0.06%)
WAGE : 51.34 (unch)
ACIA : 67.34 (+0.64%)
Hercules Capital Reports Second Quarter 2019 Financial Results

--Achieved Record Quarter for New Debt and Equity Commitments and Total Fundings of $534.8 Million and $368.1 Million, Respectively

WFC : 53.69 (-0.43%)
PINS : 17.99 (-1.21%)
TMDX : 20.01 (+0.05%)
FSLY : 21.00 (+0.86%)
BBIO : 36.93 (+1.85%)
AQ : 13.24 (unch)
MRVL : 23.68 (+0.68%)
VICL : 0.68 (-15.68%)
HTGC : 14.31 (+0.28%)
HCXZ : 25.60 (+0.20%)
HCXY : 26.35 (unch)
Hercules Capital Announces Multiple Portfolio Company Achievements in Q2 2019

Hercules Capital, Inc. (NYSE: HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture growth stage companies backed by some of the leading U.S. and...

TCDA : 43.57 (+5.57%)
INSM : 23.29 (+1.66%)
AVEO : 0.72 (+1.02%)
GNCA : 2.11 (-1.86%)
MYOV : 16.20 (+1.19%)
AQ : 13.24 (unch)
MRVL : 23.68 (+0.68%)
VICL : 0.68 (-15.68%)
PINS : 17.99 (-1.21%)
TMDX : 20.01 (+0.05%)
FSLY : 21.00 (+0.86%)
HTGC : 14.31 (+0.28%)
HCXZ : 25.60 (+0.20%)
HCXY : 26.35 (unch)
Vical: 4Q Earnings Snapshot

SAN DIEGO (AP) _ Vical Inc. (VICL) on Tuesday reported a loss of $3.6 million in its fourth quarter.

VICL : 0.68 (-15.68%)
Vical to Discontinue Clinical Development of VL-2397 as it Considers Near Term Strategic Alternatives

Vical Incorporated (Nasdaq:VICL) today announced that it has decided to discontinue the Phase 2 clinical trial of VLâ?'2397 that was initiated in the first quarter of 2018. The decision was based on the...

VICL : 0.68 (-15.68%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade VICL with:

Business Summary

Vical researches and develops biopharmaceutical products based on its patented DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Potential applications of the company's DNA delivery technology include DNA vaccines for infectious diseases or cancer, in...

See More

Key Turning Points

2nd Resistance Point 1.04
1st Resistance Point 0.86
Last Price 0.68
1st Support Level 0.55
2nd Support Level 0.42

See More

52-Week High 1.47
Fibonacci 61.8% 1.14
Fibonacci 50% 1.04
Fibonacci 38.2% 0.93
Last Price 0.68
52-Week Low 0.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar